These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33332878)

  • 61. Comparative Cardiovascular and Cerebrovascular Safety of Inhaled Long-Acting Bronchodilators in Patients with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study.
    Dong YH; Chang CH; Gagne JJ; Hsu CL; Lai MS
    Pharmacotherapy; 2016 Jan; 36(1):26-37. PubMed ID: 26799347
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Therapeutic update: non-selective beta- and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
    Sirak TE; Jelic S; Le Jemtel TH
    J Am Coll Cardiol; 2004 Aug; 44(3):497-502. PubMed ID: 15358010
    [TBL] [Abstract][Full Text] [Related]  

  • 63. β-Blockers are associated with a reduction in COPD exacerbations.
    Bhatt SP; Wells JM; Kinney GL; Washko GR; Budoff M; Kim YI; Bailey WC; Nath H; Hokanson JE; Silverman EK; Crapo J; Dransfield MT;
    Thorax; 2016 Jan; 71(1):8-14. PubMed ID: 26283710
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Underuse of beta-blockers by patients with COPD and co-morbid acute coronary syndrome: A nationwide follow-up study in New Zealand.
    Parkin L; Quon J; Sharples K; Barson D; Dummer J
    Respirology; 2020 Feb; 25(2):173-182. PubMed ID: 31401813
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Controversies and dilemmas on the use of beta-blockers in treatment of associated cardiovascular disease in patients with chronic obstructive pulmonary disease].
    Pescaru C; Tudorache V; Oancea C
    Pneumologia; 2010; 59(1):27-30. PubMed ID: 20432790
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Is a long-acting inhaled bronchodilator the first agent to use in stable chronic obstructive pulmonary disease?
    Tashkin DP
    Curr Opin Pulm Med; 2005 Mar; 11(2):121-8. PubMed ID: 15699783
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
    Suh DC; Lau H; La HO; Choi IS; Geba GP
    Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Total management of chronic obstructive pulmonary disease (COPD) as an independent risk factor for cardiovascular disease.
    Onishi K
    J Cardiol; 2017 Aug; 70(2):128-134. PubMed ID: 28325523
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cardioselective versus Non-Cardioselective Beta-Blockers and Outcomes in Patients with Atrial Fibrillation and Chronic Obstructive Pulmonary Disease.
    Vlachopoulou D; Balomenakis C; Kartas A; Samaras A; Papazoglou AS; Moysidis DV; Barmpagiannos K; Kyriakou M; Papanastasiou A; Baroutidou A; Vouloagkas I; Tzikas A; Giannakoulas G
    J Clin Med; 2023 Apr; 12(9):. PubMed ID: 37176504
    [No Abstract]   [Full Text] [Related]  

  • 70. Contemporary management of chronic obstructive pulmonary disease: scientific review.
    Sin DD; McAlister FA; Man SF; Anthonisen NR
    JAMA; 2003 Nov; 290(17):2301-12. PubMed ID: 14600189
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Beta-Blockers in High-Risk Outpatients with Chronic Obstructive Pulmonary Disease are Associated with All-Cause Mortality - The STATUETTE Cohort Study.
    Damkjær M; Suppli Ulrik C; Godtfredsen N; Håkansson KEJ
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2397-2406. PubMed ID: 34465987
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.
    Edwards SC; Fairbrother SE; Scowcroft A; Chiu G; Ternouth A; Lipworth BJ
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2851-2858. PubMed ID: 27920512
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Preventing hospitalization for COPD exacerbations.
    Bourbeau J
    Semin Respir Crit Care Med; 2010 Jun; 31(3):313-20. PubMed ID: 20496300
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long-Acting Bronchodilators for Chronic Obstructive Pulmonary Disease: Which One(S), How, and When?
    Mathioudakis AG; Vestbo J; Singh D
    Clin Chest Med; 2020 Sep; 41(3):463-474. PubMed ID: 32800199
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma.
    Chen J; Radford MJ; Wang Y; Marciniak TA; Krumholz HM
    J Am Coll Cardiol; 2001 Jun; 37(7):1950-6. PubMed ID: 11401137
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failure.
    Matera MG; Martuscelli E; Cazzola M
    Pulm Pharmacol Ther; 2010 Feb; 23(1):1-8. PubMed ID: 19833222
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Relationship of inhaled long-acting bronchodilators with cardiovascular outcomes among patients with stable COPD: a meta-analysis and systematic review of 43 randomized trials.
    Li C; Cheng W; Guo J; Guan W
    Int J Chron Obstruct Pulmon Dis; 2019; 14():799-808. PubMed ID: 31114181
    [No Abstract]   [Full Text] [Related]  

  • 78. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E; Lazarus SC
    J Allergy Clin Immunol; 2009 Nov; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The short, the long and the "ultra-long": why duration of bronchodilator action matters in chronic obstructive pulmonary disease.
    Beeh KM; Beier J
    Adv Ther; 2010 Mar; 27(3):150-9. PubMed ID: 20411368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.